Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
(BUSINESS WIRE) – Ash Stevens, Inc., a leading provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, is pleased to announce receipt of a 2014 Lilly Global Supplier ...
read more
Monday, December 13, 2021
Ascensus Specialties announced its acquisition of Wychem Limited, a UK-based manufacturer of fine chemicals for pharmaceutical and specialty applications. This transaction complements Ascensus’ existing capabilities and reinforces the Company’s focus...
read more
Ascend Advanced Therapies, a gene-to-GMP development service provider, has received GMP certification for Quality Control (QC) testing at its site in Munich, Germany.
read more
Artelo Biosciences has expanded its existing research and worldwide commercial license agreement with The Research Foundation For The State University of New York, Stony Brook.
read more
Thursday, January 02, 2020
Arena Pharmaceuticals and Beacon Discovery have entered into a strategic multi-year partnership aimed at building novel medicines across a range of GPCR targets.
read more
Tuesday, November 19, 2024
Ardena announced the full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss, Netherlands.
read more
Ardena has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients.
read more
Ardena has acquired ChemConnection, a contract manufacturer of novel APIs and nanomedicines.
read more
Wednesday, December 04, 2013
Timothy C. Tyson, Chairman of Aptuit LLC, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO), completing the company’s senior management leadership team.
read more
Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit's sales and marketing activities.
read more
Aptuit LLC announces the appointment of two new members to its Executive Leadership team. Kurt Dinkelacker has been named Executive Vice President and Chief Financial Officer and Kevin Duffield has been promoted to Vice President, Sales and Business ...
read more
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the company has launched an interactive link, “Ask an Expert,” on its website to provide informational support to the pharmaceutical community.
read more
Aptuit LLC announced that the company has innovated a translational strategy that represents a unique approach, known as “Complementary Vision,” for those in search of high value Chemistry, Manufacturing and Control (CMC) services.
read more
Monday, November 12, 2012
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the number of clients placing work at The Aptuit Center for Drug Discovery & Development in Verona, Italy has reached 100, giving the site a strong vote of confidence...
read more
Friday, February 22, 2013
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the company has formed the Aptuit Scientific Advisory Board (SAB) comprised of scientific experts from within the company. The SAB will regularly meet to assess ...
read more